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Abstract 
  Methanolic extracts from 15 medicinal plants representing 11 families, used traditionally for 
malaria treatment in Kenya were screened for their in vivo antimalarial activity in mice against a 
chloroquine (CQ)-tolerant Plasmodium berghei NK65, either alone or in combination with CQ. The 
plant parts used ranged from leaves (L), stem bark (SB), root bark (RB), seeds (S) and whole plant 
(W). When used alone, extracts from 7 plants, Clerodendrum myricoides (RB), Ficus sur (L/SB/RB), 
Maytenus acuminata (L/RB), Rhamnus prinoides (L/RB), R. staddo (RB), Toddalia asiatica (RB) 
and Vernonia lasiopus (RB) had statistically significant parasitaemia suppressions of 31.7-59.3%. In 
combination with CQ, methanolic extracts of Albizia gummifera (SB), F. sur (RB), R. prinoides and 
R. staddo (L/RB), Caesalpinia volkensii (L), Maytenus senegalensis (L/RB), Withania somnifera 
(RB), Ekebergia capensis (L/SB), T. asiatica (L/RB) and V. lasiopus (L/SB/RB) gave statistically 
significant and improved suppressions which ranged from 45.5-85.1%. The fact that these activities 
were up to 5-fold higher than that of extract alone may suggest synergistic interactions. Remarkable 
parasitaemia suppression by the extracts, either alone or in combination with CQ mostly resulted into 
longer mouse survival relative to the controls, in some cases by a further 2 weeks. Plants, which 
showed significant antimalarial activity including V. lasiopus, T. asiatica, F. sur, R. prinoides and R. 
staddo warrant further evaluation in the search for novel antimalarial agents against drug-resistant 
malaria. 
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1. Introduction 
 In view of the problems associated with antimalarial drug resistance, new drugs or drug 
combinations are urgently required today for treatment of malaria. Preferably, the new drugs should 
have novel modes of action or be chemically different from the drugs in current use (Phillipson and 
Wright, 1991). Plants have always been considered to be a possible alternative and rich source of 
new drugs and most of the antimalarial drugs in use today such as quinine and artemisinin were either 
obtained directly from plants or developed using chemical structures of plant-derived compounds as 
templates (Basco et al., 1994). Due to limited availability and/or affordability of pharmaceutical 
medicines in many tropical countries, the majority of the populations depend on traditional medical 
remedies ((WHO, 2002; Zirihi et al., 2005), mainly from plants. In ethnomedicine, same plants 
and/or related species are used for the treatment of related ailments within the same region, or across 
different regions of the world. For instance, whereas Maytenus senegalensis is used in many African 
regions for the treatment of various ailments including chest pains, rheumatism, snakebites and 
malaria, plants of the genus Maytenus are used to prepare decoctions in south America as anti-
inflammatory and analgesic remedies (Sosa et al., 2006; Ajaiyeoba et al., 2006). This is however not 
surprising since malaria manifests itself with symptoms including fever, pains and immuno-
suppression and some plants may lack direct antiplasmodial activity but may possess antipyretic, 
analgesic and immune stimulatory effects (Muregi et al., 2003). Among the plants we screened for 
antimalarial activities, most of them find wide ethnopharmacological use among different Kenyan 
ethnic groups either for similar or different ailments (Kokwaro, 1976; Beenjte, 1994). While 
Vernonia lasiopus is used against malaria by Kikuyu of central Kenya, the Kamba of eastern Kenya 
use it against scabies, the Luo of western Kenya against venereal diseases, and pounded leaves are 
applied to sores by Maasai of southern Kenya (Beentjee, 1994). Toddalia asiatica is used 
traditionally in Kenya by many communities for the treatment of malaria, fever, stomachache, 
toothache, coughs as well as nasal and bronchial pains, and although all parts of the plant are claimed 
to have medicinal value, roots are believed to be more potent (Kokwaro, 1976; Beentje, 1994).   
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 In an attempt to impede selection of drug resistance, use of monotherapy is being discouraged for 
most parasitic diseases (WHO, 2000). In the case of malaria, for instance, not only are novel 
combinations being tried, but also attempts are being made to enhance the potency and/or even 
reverse resistance of conventional drugs such as CQ (Winstanley, 2000). Although several synthetic 
molecules have been shown to restore CQ-sensitivity in resistant Plasmodium falciparum strains 
(Oduola et al., 1998), there are almost no documented data on interactions of herbal remedies with 
conventional antimalarial drugs such as CQ. In the present study, several medicinal plants used as 
traditional remedies for malaria in Kenya were evaluated for antimalarial activity against a rodent 
malaria parasite in mice, alone or in combination with the conventional antimalarial drug, CQ. 
 
2. Materials and methods 
2.1 Plant materials and extraction 
  Based on ethnomedical data, different plant parts (leaf, stem bark, root bark, seed, whole plant) of 
15 plant species representing 11 families  (Table 1) were collected in January 2004 from central 
Kenya (Mount Kenya Forest) and southern Rift Valley (Nguruman Escarpment in Magadi). The 
plants collected were identified by a taxonomic botanist from the East African Herbarium in Nairobi, 
where voucher specimens were deposited. The plant samples were then catalogued, air-dried at room 
temperature under shade, and ground into powder using an electric mill. The powder was packaged 
into one kg-packs and stored in dry and well-ventilated room until use. Organic extraction was done 
by refluxing 10g of plant material in 500 ml of methanol for one hour. The extracts were then filtered 
and concentrated to dryness in vacuo.  
2.2 The parasite and infection 
 For in vivo antimalarial assays of plant extracts, a CQ-tolerant Plasmodium berghei (strain NK65), 
a rodent malaria parasite was used. The blood-stage CQ-tolerant-induced parasite, maintained at the 
Parasite Bank of the Department of Parasitology, Hamamatsu University School of Medicine was 
previously a kind gift from Professor Y. Wataya of Okayama University, Japan. A donor mouse to 
 5
the experimental mice, having 10-15% parasitaemia was sacrificed and bled by cardiac puncture. The 
parasitaemia was adjusted downwards using physiological saline, and each of the experimental male 
ICR mice, 7-week old weighing about 30 g (Japan SLC Inc., Hamamatsu, Japan) was inoculated 
intraperitoneally with approximately 105 parasitisized erythrocytes in volumes of 0.2 ml (Ishih et al., 
2003). The inoculated mice were then randomized into 5 mice per cage and maintained in an animal 
care facility on a commercial diet and water ad libitum.  
 
2.3 Antimalarial activity of plant extracts either alone or in combination with chloroquine 
 In screening of the plant extracts alone, the 4-day suppressive method of Peters et al. (1975) was 
used. Within 3 hours post-inoculation of mice with the parasite (i.e on day 0), treatment of the 
experimental groups was initiated by oral administration of the test extract at a dose of 500 mg/kg 
body weight and treatment was done twice a day (at 8-hour interval) for 4 days, up to day 3 post-
infection (p.i.). The untreated control group received distilled water only. Twenty-four hours after the 
last treatment (i.e., on day 4 p.i.), parasitaemia of individual mouse was determined by microscopic 
examination of Giemsa stained thin blood smears prepared from mouse-tail blood. 
      In assessing the in vivo interactions of CQ and the plant extracts, treatment was started on day 4 
p.i. based on the method of Ishih et al. (2004). Infected mice were randomized into CQ/plant extract 
treated groups [CQ, 20 mg/kg body weight, once a day for 2 days + plant extract, 500 mg/kg body 
weight, twice a day for 4 days], a CQ-treated positive control group, and an untreated control group, 
which received water only. For all mice before initial treatment on day 4 p.i., thin blood smears were 
prepared, after which CQ dose followed by plant extract dose was administered by oral route.   
      In both studies, in vivo antimalarial activity of the test drugs was assessed by monitoring mouse 
survival and parasitaemia, over a 30-day period. Handling of animals was done in accordance to the 
Guide for the Care and Use of Laboratory Animals, Hamamatsu University School of Medicine. 
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2.4 Data and statistical analysis 
 Percentage suppression of parasitaemia for the plant extracts was calculated as: 100 - [(mean 
parasitaemia treated/mean parasitaemia control) × 100] (Gessler et al., 1995). For comparison of 
average parasitaemia, one-way ANOVA and 2-tailed Student’s t-test were used (Microsoft® Excel 
2004), with P<0.05 being considered significant.  
    
3. Results  
3.1 Antimalarial activity of plant extracts alone 
 Table 2 shows a summary of parasitaemia suppression (%) for mice on day 4 p.i. and their 
corresponding survival on day 9 p.i., when 100% mouse-mortality of the untreated control occurred. 
Eleven extracts from 7 plant species showed significant parasitaemia suppressions (P<0.05) ranging 
from 31.7-59.3%. These are C. myricoides (RB), F. sur  (L/SB/RB), M. acuminata (L/ RB), R. 
prinoides (L/RB), R. staddo (RB), T. asiatica (RB) as well as V. lasiopus (RB). In contrast, other 14 
extracts, C. volkensii (S), M. heterophylla (RB), M. senegalensis (RB), V. lasiopus (SB), A. remota 
(W), E. capensis (L/SB/RB), A. indica (L), A. gummifera (L/SB), F. sur (L), R. staddo (L), and C. 
myricoides (L), had non-significant suppressions (P>0.05), which ranged from 9.8-37.0%. Three 
extracts from C. volkensii (L), M. heterophylla (RB) and V. lasiopus (L) had no activity at all. Based 
on day 9 p.i. relative to the untreated controls, 7 extracts gave a 40-60% mouse survival, in some 
cases up to a further 2 weeks. T. asiatica (L) had a 60% and 40% mouse survival on day 9 and 16 p.i. 
respectively. Although the extract had moderate suppression of 37.0% (P>0.05) on day 4 p.i., it is the 
only extract that showed sustained effect on day 7 p.i. of 39.8% (P<0.05) relative to the untreated 
controls. V. lasiopus (RB) gave a 60% survival of mice on day 9 p.i. and a  40% survival on day 11 
p.i. C. volkensii (S) and A. gummifera (SB) had 40% survival  on day 18 p.i., and 17 p.i. respectively.  
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3.2 Antimalarial activity of plant extracts in combination with CQ 
 In CQ/plant extract combination studies, the parasitaemia levels on day 4 p.i. (before initial 
treatment) were not different (P>0.05) among all groups and microscopic examination of day 8 p.i. 
smears detected no parasites. However, the recrudescent parasites reappeared by day 11 p.i., and 
hence parasitaemia levels at day 11 p.i.  were considered the most significant in assessment of 
chemo-suppression. Table 2 summarizes the parasitaemia suppression (%) for mice on day 11 p.i. 
and the corresponding survival on day 14 p.i., when all mice of CQ-treated control group died. 
 Seventeen extracts from A. gummifera (SB), F.sur (RB), M. senegalensis (L/RB), R. prinoides 
(L/RB), R. staddo (L/RB), C. volkensii (L), E.capensis (L/SB), T. asiatica (L/RB), V. lasiopus (L/SB/ 
RB) as well as W. somnifera (RB) in combination with CQ gave parasitaemia suppressions that 
ranged from 45.5-85.1% (P<0.05).  The best activities were exhibited by CQ/A. gummifera (SB), CQ/ 
F.sur (RB), CQ/R. prinoides (RB) as well as CQ/R. staddo (RB) with activities of 75.2, 79.3, 85.1 
and 74.2% respectively. Nine extracts in combination with CQ including C. volkensii (S), Maytenus 
acuminata (L), M. acuminata (RB) and M. heterophylla (RB) showed non-significant (P>0.05) 
activities of up to 45.5%, while 2 extracts, F. sur (L/SB) had no suppression at all  (Table 2). Relative 
to day 14 p.i., when 100% mortality of the CQ-alone treated controls occurred, mice in the groups 
treated with CQ/R. staddo (RB) had the highest  mouse survival  of 80% at day 14 p.i., and 40% 
survival on day 26 p.i. CQ/V. lasiopus (L) had 60 and 40% survival on day 14 and 26 p.i. 
respectively. The 2 extracts had mice surviving longer by up to a further 2 weeks (day 28 p.i.) 
relative to the controls. CQ/A. gummifera (SB) gave a 60% survival on day 14 p.i., but all the mice 
died by day 17 p.i. It is remarkable that all the 3 groups had shown significant parasitaemia 
suppressions of 74.2, 56.1 and 75.2% respectively. Although CQ/E. capensis (RB) maintained a 75% 
survival up to day 23 p.i, and 50% survival on day 28 p.i., it is remarkable that the combination had 
day 11 p.i. parasitaemia suppression of 37.9% which was not statistically significant (P>0.05). Three 
extracts showed a considerably longer mouse survival than the controls; CQ/Azadirachta indica (L), 
40% survival on day 25 p.i.; CQ/R staddo (L), 50%  survival on day 30 p.i.; CQ/T asiatica (L ), 40% 
mouse survival on day 24 p.i.  
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4. Discussion and conclusions 
 When assayed alone against CQ-torelant P. berghei NK65, 38% of the 29 methanolic extracts, 
representing 53% of all the 15 plant species screened, showed significant parasitaemia suppression 
(P<0.05) on day 4 p.i. ranging from 31.7-59.3%, which may partially validate the ethnomedical  use 
of the herbs in management of malaria. The plants with considerable in vivo chemo-suppression 
including V. lasiopus, F. sur, C. myricoides, R. prinoides and R. staddo had shown moderate to 
significant in vitro antiplasmodial activities against both CQ-sensitive and -resistant P. falciparum 
isolates in their water and/or organic fractions in a previous study of some Kenyan medicinal plants 
(Muregi et al., 2003; 2004). The organic leaf extract of V. lasiopus had shown the highest in vitro 
inhibition of parasite growth, with IC50 values as low as 1.0 μg/ml, which is consistent with the 
findings of the present study, in which the methanolic extract showed a remarkable in vivo 
parasitaemia suppression of 59.3%, albeit in its root bark extract. The presence and/or quantities of 
bioactive compounds in plants are influenced by several factors including seasons, environment, 
plant-part used, intra-species variations and plant age (Weenen et al., 1990), and this may explain the 
discrepancies observed in in vitro and in vivo activities of plant parts used. Many Vernonia species 
have been investigated chemically and found to contain several metabolites including triterpenes and 
oxygenated sesquiterpenes, flavones and vernolic acid (Oketch-Rabah, 1996). Oxygenated 
sesquiterpene lactones are the most abundant secondary metabolites of the genus Vernonia, and since 
artemisinin, isolated from the Chinese herb Artemisia annua belongs to the same class of compounds 
and has been widely used in the synthesis of semi-synthetic antimalarials effective against multi-drug 
resistant strains of P. falciparum (Trigg, 1989; Oketch-Rabah, 1996), it is important to investigate 
Vernonia species further. Two 5-methylcoumarins isolated from the roots of V. brachycalyx showed 
in vitro antiplasmodial activity against both CQ-sensitive and –resistant P. falciparum isolates 
(Oketch-Rabah et al., 1997). Methanolic extract of T. asiatica (RB) showed remarkable activity 
(59.3%) in the present study, and was previously reported to possess high in vitro antiplasmodial 
activity, with a mean 50% inhibitory dose of 0.98 μg/ml (Gakunju et al., 1995). Subsequent activity-
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guided fractionation and isolation afforded fractions and an alkaloid, nitidine, active against both CQ-
sensitive and -resistant P. falciparum isolates. Subsequent chemical development of this compound 
has further improved its potency against CQ-resistant P. falciparum isolates in vitro (Waigh, 2002). 
Oketch-Rabah et al. (2000) reported that a coumarin derivative from T. asiatica (RB) had a moderate 
in vitro activity of 8.8 μg/ml against P. falciparum isolates. Although not much has been reported in 
literature about biological activity of F. sur, it is widely used in Kenyan ethnopharmacology as a 
cough remedy, against stomachaches and toothaches to relieve pain (Kokwaro, 1976; Beenjte, 1994). 
The fact that all the F. sur parts investigated showed a modest antimalarial activity underscores the 
need for further investigation of the plant. R. staddo and R. prinoides are the only 2 Rhamnus species 
that occur in Africa and the latter is widespread in many parts of eastern and central Africa (Abegaz 
et al., 1999). In ethnomedicine, the 2 plants, especially their roots are used for treatment of malaria, 
indigestion, venereal diseases and rheumatism among other ailments (Kokwaro, 1976; Beenjte, 1994). 
Recent studies have shown that R. prinoides can serve as a commercial hopping agent in the brewery 
industries and 20 compounds including 7 glycosides of emodin anthrone, 5 flavonoids and 3 
naphthalenic derivatives were isolated from the plant (Abegaz et al., 1999). Emodin has been 
reported to possess various pharmacological and biological activities including immunostimulation, 
antiparasitic, anti-inflammatory and analgelsic effects, among others (Izhaki, 2002). In several cases, 
remarkable suppression of parasitaemia by extracts translated into either a higher and/or a longer 
mouse survival. However, V. lasiopus (RB) gave a 60% survival of mice on day 9 p.i. and a  40% 
survival on day 11 p.i., which mean that high percentage survival on day 9 p.i. does not translate into 
a considerably longer mouse survival. This may suggest that the bioactive compound in the plant 
may have a short half-life, since some antimalarial drugs including artemisinin-based derivatives are 
known to be fast acting, and to have a short half-life (Van Agtmael et al., 1999). In contrast, T. 
asiatica (L) gave a 60% mouse survival on day 9 p.i., and a relatively longer survival, with 40% 
mouse survival on day 16 p.i. The extract is the only one which maintained similar suppression levels 
on day 4 and 7 p.i., suggesting that the bioactive agent (s) in the plant may have a slow onset of 
action, and/or that it is not fast acting. On the other hand, some extracts with mild parasitaemia 
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suppression (P>0.05) gave a long mouse survival. C. volkensii (SD) and A. gummifera (SB), with 
40% survival  on day 18 p.i., and 17 p.i. respectively are such extracts, implying that other than direct 
parasiticidal effects, plants may possess other pharmacological benefits to the hosts, such as acting as 
analgesics, antipyretics or as immune stimulators (Dahanukar et al., 2000).   
      In combination with CQ, some of the extracts showed up to 5-fold better chemo-suppression as 
well as longer mouse survival than that of CQ-alone treated controls, suggesting synergistic 
interactions of the 2 drugs. As expected, high chemo-suppression in most cases led to a high mouse 
survival at day 14 p.i., and subsequently a longer mouse survival, as in the case of the group treated 
with CQ/R. staddo (RB). Some plant extracts such V. lasiopus (L) that lacked activity when used 
alone, demonstrated both high as well as prolonged mouse survival when used in combination with 
CQ. As earlier noted, this emphasizes the possibility of other pharmacological effects of plants being 
involved, besides direct antiparasitic effects. Leaves and seeds of V. lasiopus and V. galamensis had 
been reported to possess analgesic effects in rat models (Dahanukar et al., 2000). On the other hand, 
some extracts including F. sur (L/ RB) which had significant activity when used alone showed little 
or no suppression in combination with CQ.  Antagonistic interactions among drugs as well as toxicity 
cannot be ruled out in such cases, emphasizing the need to avoid simultaneous use of conventional 
drugs with natural products before the safety and efficacy of such combinations have been 
authenticated. The fact that about 50% of the 15 plants screened showed moderate to high in vivo 
antimalarial activity when used alone, and that most of the extracts enhanced CQ activity forms a 
basis of further detailed studies of the plants. This includes isolation and characterization of the 
bioactive compounds with the ultimate objective of finding novel antimalarial compound(s), which 
can be used in the fight against drug-resistant malaria. 
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Table 1.  Plant parts collected based on ethnopharmacological data and  percentage yield of dry 
methanolic extract per 10 g of  air-dried plant material used 
 
Plant Family  Vernacular name Plant part used  % Yield 
of   
Botanical name  (Kikuyu)a    (Specimen code)  plant 
extract 
 
Caesalpinaceae 
 Caesalpinia volkensii Harms Mucuthi  L (Cv-L/04)  14 
                 Sd (Cv-S/04)  18 
Celastraceae  
  Maytenus acuminata (L.f.) Loes Rurigi L (Ma-L/04) 18 
   Rb (Ma-RB/04) 20 
  M. heterophylla (Eckl. & Zeyh.) Robson Muthuthi  Rb (Mh-RB/04)   6 
 M. senegalensis (Lam.) Exell Muthuthi/  L (Ma-L/04) 14
 Mwenyuke  Rb (Ma-RB/04) 14 
Compositae  
 Vernonia lasiopus O.Hoffm. Mucatha  L (Vl-L/04)   9
 Sb (Vl-SB/04 14  
 Rb (Vl-RB/04) 22 
Labiatae  
 Ajuga remota Benth. Njeri-wa-rurii Wp (Aj-W/04) 22 
Meliaceae  
Ekebergia capensis Sparrm. Mununga/ L (Ec-L/04)   9  
    Murera-hungu Sb (Ec-SB/04) 26 
   Rb (Ec-RB/04)  21   
 Azadirachta indica A. Juss. Murumbaine L (Ai-L/04) 10 
Mimosaceae  
  Albizia gummifera (JF Gmel.) C.A. Sm. Mukurue  L (Ag-L/04)    5 
   Sb (Ag-SB/04)     4 
Moraceae  
 Ficus sur Forssk. Mukuyu L (Fs-L/04)   6 
   Sb (Fs-SB/04)     7
   Rb (Fs-RB/04)     9 
Rhamnaceae  
 Rhamnus prinoides L’ Hérit  Mukarakinga L (Rp-L/04) 24 
    Rb (Rp-RB/04) 25 
  R. staddo A.Rich. Mubura L (Rs-L/04) 10 
 Rb (Rs-RB/04) 30 
Rutaceae  
  Toddalia asiatica (L.) Lam. Mwikunya/  L (Ta-L/04)   5 
 Mururue Rb (Ta-RB/04) 20 
Solanaceae  
  Withania somnifera (L.) Dunal Murumbae Rb (Ws-RB/04) 10 
Verbenaceae  
 Clerodendrum myricoides (Hochst.) Vatke Munjuga-iria L (Cm-L/04)   8  
    Rb (Cm-
RB/04) 25  
 
L, leaf; SB, stem bark; RB, Root bark; S, seed; W, whole plant  
a some plant species may share vernacular names while others may have more than one name   
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Table 2.  Parasitaemia suppression (%) on day 4 and 11 post infection (p.i.) for mice treated with 
plants’ methanolic extracts alone (from day 0 p.i.) and in combination with CQ (from day 4 p.i), and 
the corresponding survival (%) on day 9 and 14 p.i. respectively 
 
 Extract alone  CQ +extract  
Drug  
 Suppression (%) Survival (%)  Suppression (%) Survival 
(%) 
 on day 4 p.i.  on day 9 p.i.  on day 11 p.i. on day 14 p.i. 
 
Caesalpinia volkensii (L) NS      0 47.0b 20 
C. volkensii (S)  33.3   40 33.3    0
Maytenus acuminata (L) 36.6b    0 30.6 40
M. acuminata (RB) 41.5b    0 0.8 20
M. heterophylla (RB) 9.8    0 6.6   0
M. senegalensis (L) NS  20 55.4b 40 
M. senegalensis (RB) 2.4  20 56.2b 20 
Vernonia lasiopus (L) NS    0 56.1b 60
V. lasiopus (SB) 14.8   0 63.6b 20 
V. lasiopus (RB) 59.3b 60  62.1b 40 
Ajuga remota (W) 26.8    0  7.4 20 
Ekebergia capensis (L) 14.8  20 59.1b 20 
E. capensis (SB) 33.3  40  45.5b 20 
E. capensis (RB) 22.2  20 37.9  75 
Azadirachta indica (L) 22.2  20 45.5 40 
Albizia gummifera (L) 19.5    0 43.0 40 
A. gummifera (SB) 31.7 40 75.2b 60 
Ficus sur (L) 43.9b  20 NS   0 
F. sur (SB) 34.1b 20 NS   0 
F. sur (RB) 48.8b   0 79.3b 20 
Rhamnus prinoides (L) 43.9b   0 64.5b   0 
R. prinoides (RB) 34.1b  20 85.1b 40 
R. staddo (L) 11.1  20 57.6b 50 
R. staddo (RB) 48.1b 40 74.2b 80 
Toddalia asiatica (L) 37.0 60 57.6b 40 
T. asiatica (RB) 59.3b 40 53.0b 20 
Withania somnifera (RB) ND    0 45.5b 50 
Clerodendrum myricoides (L) 9.8    0 14.9   0 
C. myricoides (RB) 31.7b   0 ND     
    
Water control -      0 ND  
CQ control 100 100 -    
0    
 
L, leaf; SB, stem bark; RB, Root bark; S, seed; W, whole plant 
NS, no suppression; ND, not determined  
bstatistically significant (P<0.05) 
 
